Abevmy 100 mg/4 ml
Abevmy 100 mg/4 ml is a medicine authorised by Swissmedic under authorisation number 70261. The authorisation holder is Medius AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 03 November 2025 and the authorisation is limited until 02 November 2030. ATC code L01FG01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 70261 |
|---|---|
| Name | Abevmy 100 mg/4 ml |
| Full name | Abevmy 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Medius AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FG01 |
| First authorisation | 03 November 2025 |
| Authorisation validity | 02 November 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Abevmy 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 03 November 2025 |
| 2 | Abevmy 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 03 November 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FG01 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FG01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Abevmy 100 mg/4 ml authorised in Switzerland?
Yes. Abevmy 100 mg/4 ml is authorised by Swissmedic under authorisation number 70261, data as of 01 September 2026. The authorisation is limited until 02 November 2030.
Which dispensing category does Abevmy 100 mg/4 ml have?
Abevmy 100 mg/4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Abevmy 100 mg/4 ml?
The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.